| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| CAR_RIC - Bandi Fondazione Cariplo |
Role of CHIP/STUB1 in the clearance of toxic proteins responsible for repeat expansion neurodegenerative diseases
|
|
Ongoing | 2022 |
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia (RECOGNISED)
|
|
Ongoing | 2020 |
| PRIN2020 - PRIN bando 2020 |
RE-Plast: targeting functional and structural plasticity in Alzheimer disease. From diagnosis to treatment
|
|
Ongoing | 2022 |
| PSR_LINEA2_ / Piano di sviluppo di ricerca - Dotazioni dipartimentali - Linea 2 |
Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2021)
|
|
Ongoing | 2022 |
| MIS - Bandi Ministero Salute |
Phase III trial of dopaminergic therapy with rotigotine in patients with mild Alzheimer's disease (DOPAD3)
|
|
Ongoing | 2021 |
| FON_NAZ - Bandi Altre Fondazioni |
Pharmacological block of the prokineticin system and of microglia activation to treat pain and mood disorders in Fabry-Anderson disease
|
|
Ongoing | 2022 |
| Horizon Europe - European Partnership |
Partnership for the Assessment of Risks from Chemicals (PARC)
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
Optimizing Management of Comorbid NASH through a Multidisciplinary Integration and Artificial Intelligence Alliance (OPTIMA-NASH)
|
|
Ongoing | 2022 |
| Progetti PNRR - Partenariati estesi a Università per attività di ricerca |
One Health Basic and Translational Research Actions addressing Unmet Need on Emerging Infectious Diseases (INF-ACT)
|
|
Ongoing | 2022 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
Next generation advanced RNA inhibition therapy to treat cardiometabolic disease (LiverTarget)
|
|
Ongoing | 2022 |
